Global Lancets Market Growth 2023-2029

Global Lancets Market Growth 2023-2029

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.

These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
LPI (LP Information)' newest research report, the “Lancets Industry Forecast” looks at past sales and reviews total world Lancets sales in 2022, providing a comprehensive analysis by region and market sector of projected Lancets sales for 2023 through 2029. With Lancets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lancets industry.
This Insight Report provides a comprehensive analysis of the global Lancets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lancets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Lancets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lancets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lancets.
The global Lancets market size is projected to grow from US$ 1424.5 million in 2022 to US$ 1978.2 million in 2029; it is expected to grow at a CAGR of 1978.2 from 2023 to 2029.
The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Ordinary lancets is the main type, with a share about 75%. Glucose tests is the main application, which holds a share about 70%.
This report presents a comprehensive overview, market shares, and growth opportunities of Lancets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Safety Lancets
Ordinary Lancets
Segmentation by application
Cholesterol Tests
Glucose Tests
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
AgaMatrix
Smiths Medical
Sarstedt
Sinocare
Yicheng
Yuwell
Greiner Bio One
Key Questions Addressed in this Report
What is the 10-year outlook for the global Lancets market?
What factors are driving Lancets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lancets market opportunities vary by end market size?
How does Lancets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.